STAPHYLOCOCCUS AUREUS FIBRONECTIN-BINDING ADHESINS

描述（由申请方提供）：金黄色葡萄球菌仍然是导致皮肤和深部软组织感染的主要人体病原体，可能使植入器械和手术伤口部位复杂化。对抗生素具有耐药性的葡萄球菌菌株的日益流行对患者和公众健康构成了威胁。需要新的预防和治疗方法来对抗这种病原体。由于葡萄球菌对宿主组织的粘附对于定植和感染至关重要，因此葡萄球菌表面蛋白可能是细菌与宿主之间的第一个接触点，因此是重要的预防目标。在与宿主结构结合的葡萄球菌表面蛋白中，纤连蛋白结合蛋白（FnBP）是主要的纤连蛋白（Fn）结合粘附物，并在体外介导细菌粘附和细胞内侵入。最近的一项研究证实了FnBP在心内膜炎模型中引发感染的重要性。不幸的是，使用FnBP作为疫苗靶标的大多数尝试都受到抗FnBP抗体的不良阻断能力的阻碍。在非疫苗方法中，S.金黄色葡萄球菌已被用于预防豚鼠模型中伤口感染的建立。FnBP的这种作用模式的一种解释是，它竞争性地阻断葡萄球菌与宿主靶标如Fn和/或其他受体的结合。这种FnBP片段在伤口感染预防中的预防作用可能广泛适用于大多数S。考虑到结合Fn的能力对于几乎所有的葡萄球菌菌株都是常见的，因此可以将Fn与金黄色葡萄球菌菌株结合。将来自使用重组和合成FnBP构建体的FnBP分子的先前研究的观察结果应用于伤口感染模型，以努力鉴定FnBP内负责该动物模型中的预防作用的关键区域。此外，将检查可能在FnBP的预防作用中起作用的抗粘附和/或炎症机制。FnBP作为抗粘附素的使用为预防S.金黄色葡萄球菌感染

DESCRIPTION (provided by applicant): Staphylococcus aureus continues to be a major human pathogen causing skin and deep soft-tissue infections that may complicate implanted devices and surgical wound sites. The increasing prevalence of staphylococcal strains that are resistant to antibiotics looms as a threat to patients and the public health. Novel preventive and therapeutic approaches are needed for combating this pathogen. Since adherence of staphylococci to host tissues is critical for colonization and infection, staphylococcal surface proteins are likely to be the first point of contact between the bacterium and the host and, thus, are important preventive targets. Of the staphylococcal surface proteins that bind to host structures, the fibronectin-binding proteins (FnBP) are the major fibronectin (Fn)-binding adhesions and mediate bacterial adherence and intracellular invasion in vitro. A recent study has confirmed the importance of FnBP in the initiation of infection in an endocarditis model. Unfortunately, most attempts to use FnBP as a vaccine target have been hampered by poor blocking capacity of anti-FnBP antibodies. In a non-vaccine approach, a fragment of the FnBP of S. aureus has been used to prevent the establishment of wound infection in a guinea pig model. One explanation of this mode of action of FnBP is that it competitively blocks the binding of staphylococci to host targets such as Fn and/or other receptors. The preventive effects of this FnBP fragment In wound infection prophylaxis are likely broadly applicable to most S. aureus strains given that the capacity to bind Fn is common for almost all staphylococcal strains. Observations from prior studies of the FnBP molecule using recombinant and synthetic FnBP constructs will be applied to the wound infection model in an effort to identify critical regions within FnBP that are responsible for the preventive effect in this animal model. Also, anti-adhesive and/or inflammatory mechanisms that may be operative in the preventive effect of FnBP will be examined. The use of FnBP as an anti-adhesin presents a novel therapeutic tool for the prevention of S. aureus infections.